Back to Ghk-cu research
ghk-cu copper peptide in vitro n preclinical 2026-04-03 PubMed

GHK-Cu analogues match or exceed GHK cell growth activity with superior serum stability

Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity.

Background

Glycyl-L-histidyl-L-lysine (GHK) is a naturally occurring tripeptide with well-documented roles as a cell growth factor, functioning through copper complex formation. Its mechanism as a growth-promoting signal is incompletely understood — specifically, which residues drive receptor interaction versus metal coordination remains unresolved. Current cell culture media supplementation relies on GHK or serum-derived factors, but endogenous peptides like GHK are vulnerable to rapid enzymatic degradation in serum, limiting their utility. Understanding which structural features of GHK are essential — the imidazole of His, the amine of Lys, or the copper-chelating Gly terminus — is critical for designing stable synthetic analogues with preserved or enhanced biological activity.

Study Design

GHK and two synthetic analogues (His replaced with L-spinacine or L-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid) were studied for copper complex formation using potentiometry, solution calorimetry, UV-VIS spectrophotometry, circular dichroism, and electron paramagnetic resonance spectroscopies across a range of pH conditions. Enzymatic stability of all three tripeptides was assessed in human serum over a minimum 3-hour observation window. Cell growth factor activity was evaluated in vitro, including experiments conducted in the presence of serum, to assess practical applicability as cell culture media additives.

Results

All three ligands formed copper complexes with distinct stoichiometries and stabilities; evidence for binuclear species formation was also demonstrated. The lateral lysine amino group was shown to participate in copper complex formation, but only at alkaline pH — at physiological pH this group remains protonated and is therefore available for interactions with cellular receptors rather than metal coordination. The first residue (Gly) was identified as the primary driver of copper complex formation, while the second residue (His) was found not to play a specific structural role in complex geometry or biological function.

The two synthetic analogues showed no significant degradation in human serum for at least 3 hours, and exhibited cell growth factor activity comparable to or even higher than GHK, establishing them as viable serum-stable alternatives.

The free side chain of the third residue (Lys) was identified as being of fundamental importance for growth factor activity, linking receptor-available Lys to the biological mechanism rather than to copper coordination at physiological pH.

Key Findings

  • Both synthetic His-substituted GHK analogues showed cell growth factor activity comparable to or higher than native GHK
  • No significant serum degradation of synthetic analogues observed over at least 3 hours in human serum
  • Gly (first residue) drives copper complex formation; His (second residue) plays no specific mechanistic role
  • Free Lys side chain identified as fundamentally important for growth factor activity at physiological pH
  • Evidence of binuclear copper complex species formation demonstrated for all three tripeptide ligands

Why It Matters

Copper complex formation initiated at the Gly residue is necessary for GHK's growth factor activity, but the His residue is dispensable — meaning researchers and formulators can substitute His with synthetic amino acids without sacrificing efficacy. The free Lys side chain at physiological pH appears to mediate receptor interactions, which has direct implications for how GHK-Cu is dosed and whether Lys-blocking modifications would ablate activity. For those using GHK-Cu in cell culture or topical protocols, serum-stable analogues that persist at least 3 hours without degradation represent a meaningful formulation advantage. Clinically, these findings suggest rational GHK-Cu analogue design is feasible and that synthetic replacements could outperform the native peptide in stability-sensitive environments.

TitrateLab articles covering GHK-Cu

Written by TitrateLab, separately from the study summarized above.


ghk-cu ghk copper peptide healing peptide copper-chelation cell-growth-factor lysine-receptor-interaction
Source: pubmed:11325542 · Ingested Apr 3, 2026 · Digest: claude-sonnet-4-6